Which has the lower trailing P/E, CI or TMO?

CI has the lower trailing P/E: CI trades at 11.97 and TMO at 34.36. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or TMO?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus TMO at 5.00%.

Does CI or TMO pay a bigger dividend?

CI yields 2.20% and TMO yields 0.30% based on trailing dividends and the latest price.

Is CI or TMO more profitable?

TMO runs the higher net margin — CI at 2.27% versus TMO at 15.06%.

How have CI and TMO total returns compared?

Over the past 10 years, CI delivered 9.29% and TMO delivered 15.88% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs Thermo Fisher Scientific Inc. (TMO)

A side-by-side comparison of Cigna Corporation and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$76.44B

$289.27HealthcareDelayed quote: Sep 15, 2026, 3:30 PM EDT

TMO

Thermo Fisher Scientific Inc.

$237.40B

$638.83HealthcareDelayed quote: Sep 15, 2026, 3:30 PM EDT

Total return — CI vs TMO

growth of $100 · dividends reinvested · last 10y

CI +144.7% (+9.4%/yr)TMO +317.8% (+15.4%/yr)TMO compounded faster over this window

CI TMO

CI vs TMO: by the numbers

•TMO is the larger company ($237.40B vs $76.44B market cap).
•CI trades at the lower trailing earnings multiple (11.97 vs 34.36 P/E), one valuation lens rather than an overall verdict.
•TMO converts more revenue to profit (15.06% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 5.00% CAGR).
•CI pays the higher dividend yield (2.20% vs 0.30%).

Metrics side by side

Valuation

Metric	CI	TMO
P/E ratio	11.97	34.36
Forward P/E	9.48	25.44
P/S ratio	0.27	5.12
P/B ratio	1.79	4.51
EV / EBITDA	8.27	26.27
FCF yield	11.92%	3.08%

Profitability

Metric	CI	TMO
Gross margin	11.66%	40.37%
Operating margin	3.46%	17.69%
Net margin	2.27%	15.06%
ROE	15.05%	13.25%
ROIC	7.69%	7.44%

Dividends

Metric	CI	TMO
Dividend yield	2.20%	0.30%
Payout ratio	25.62%	9.68%

Growth (annualized)

Metric	CI	TMO
Revenue CAGR (5Y)	11.11%	5.00%
EPS CAGR (5Y)	-0.76%	1.99%
FCF CAGR (5Y)	-1.95%	-1.83%
Total return CAGR (5Y)	8.52%	1.57%

Frequently asked

Which has the lower trailing P/E, CI or TMO?: CI has the lower trailing P/E: CI trades at 11.97 and TMO at 34.36. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or TMO?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus TMO at 5.00%.
Does CI or TMO pay a bigger dividend?: CI yields 2.20% and TMO yields 0.30% based on trailing dividends and the latest price.
Is CI or TMO more profitable?: TMO runs the higher net margin — CI at 2.27% versus TMO at 15.06%.
How have CI and TMO total returns compared?: Over the past 10 years, CI delivered 9.29% and TMO delivered 15.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio Thermo Fisher Scientific P/E ratio Cigna dividend yield Thermo Fisher Scientific dividend yield Cigna ROE Thermo Fisher Scientific ROE Cigna operating margin Thermo Fisher Scientific operating margin Cigna revenue growth Thermo Fisher Scientific revenue growth Cigna free cash flow Thermo Fisher Scientific free cash flow

Cigna & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.